Chrysostomou, Stelios, Roy, Rajat, Prischi, Filippo, Thamlikitkul, Lucksamon, Chapman, Kathryn L, Mufti, Uwais, Peach, Robert, Ding, Laifeng, Hancock, David, Moore, Christopher, Molina-Arcas, Miriam, Mauri, Francesco, Pinato, David J, Abrahams, Joel M, Ottaviani, Silvia, Castellano, Leandro, Giamas, Georgios, Pascoe, Jennifer, Moonamale, Devmini, Pirrie, Sarah, Gaunt, Claire, Billingham, Lucinda, Steven, Neil M, Cullen, Michael, Hrouda, David, Winkler, Mathias, Post, John, Cohen, Philip, Salpeter, Seth J, Bar, Vered, Zundelevich, Adi, Golan, Shay, Leibovici, Dan, Lara, Romain, Klug, David R, Yaliraki, Sophia N, Barahona, Mauricio, Wang, Yulan, Downward, Julian, Skehel, J Mark, Ali, Maruf M U, Seckl, Michael J and Pardo, Olivier E (2021) Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer. Science translational medicine, 13 (602). ISSN 1946-6242.